Mouth Neoplasms

21 registered clinical trials studyying Mouth Neoplasms — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer NCT06848439	Jiangsu Cancer Institute & Hospital	Phase 2
Recruiting	Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and F NCT07401641	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	N/A
Recruiting	Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative NCT05774483	Tata Memorial Hospital	N/A
Completed	Visual Oral Examination for Early Detection of Oral Cancer in High-Risk Individuals NCT06231537	Universidade Federal do Rio de Janeiro	N/A
Recruiting	Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD) NCT05296941	Dalarna County Council, Sweden	N/A
Completed	A New Membrane Obturator Prothesis Concept for Soft Palate Defects NCT04009811	University Hospital, Bordeaux	N/A
Unknown	GDF15 Based TPF Induction Chemotherapy for OSCC Patients NCT02285530	Shanghai Jiao Tong University School of Medicine	Phase 2
Terminated	A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients NCT02285543	Shanghai Jiao Tong University School of Medicine	Phase 2
Recruiting	Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage NCT02290145	Shanghai Jiao Tong University School of Medicine	Phase 2
Completed	Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity NCT02604121	University Hospital, Toulouse	N/A
Completed	GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer NCT01553851	Washington University School of Medicine	Phase 2
Completed	The Feasibility Study of Dual-Section Nasogastric Tube NCT01649349	Changhua Christian Hospital	EARLY_Phase 1
Terminated	Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer NCT01216020	Azienda USL 4 Prato	Phase 2
Completed	Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma NCT01195922	National Institute of Dental and Craniofacial Research (NIDCR)	Phase 1 / Phase 2
Completed	Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers NCT01104714	Centre Hospitalier Universitaire de Nīmes	—
Completed	Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity NCT00953849	VA Office of Research and Development	Phase 1 / Phase 2
Completed	F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients NCT00721799	University of Iowa	Phase 2
Terminated	Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer NCT00272181	Sesen Bio, Inc.	Phase 2
Terminated	Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and N NCT00412776	Sesen Bio, Inc.	Phase 2 / Phase 3
Unknown	Oral Cancer Adjuvant Therapy (OCAT) Trial NCT00193843	Tata Memorial Hospital	Phase 3
Completed	Biomarkers for Oral Cancer NCT00341497	National Cancer Institute (NCI)	—